[Cardiovascular effects and estrogen/gestagen substitution therapy]

Area of Science:

• Endocrinology
• Cardiovascular Medicine
• Lipid Metabolism

Context:

• Post-menopausal women experience a significant increase in cardiovascular diseases, primarily due to estrogen deficiency-induced atherosclerosis.
• Key mechanisms include elevated LDL-cholesterol and triglycerides from impaired liver clearance, and enhanced LDL oxidation in arterial walls.
• Estrogen deficiency also facilitates vasospasms and platelet aggregation, increasing ischemia risk.

Purpose:

• To elucidate the mechanisms by which estrogen deficiency contributes to cardiovascular disease development after menopause.
• To evaluate the efficacy of estrogen replacement therapy in mitigating cardiovascular risk in post-menopausal women.
• To explore the multifaceted actions of estrogens on lipid metabolism, LDL oxidation, and vascular function.

Summary:

• Estrogen deficiency elevates cardiovascular disease risk by promoting atherosclerosis through impaired lipid metabolism and increased LDL oxidation.
• Estrogen replacement therapy demonstrates a 30-50% reduction in cardiovascular disease risk, independent of progestogen co-administration.
• Estrogens improve lipid profiles by increasing HDL, enhancing LDL clearance, and inhibiting LDL oxidation via free radical scavenging. They also promote vasodilation, potentially via endothelium-dependent mechanisms and calcium channel blockade.

Impact:

• Estrogen therapy offers significant cardiovascular protection for post-menopausal women, reducing disease risk by up to 50%.
• Understanding these mechanisms provides a basis for targeted therapeutic strategies to prevent and manage cardiovascular diseases in aging women.
• The findings underscore the critical role of estrogen in maintaining cardiovascular health and highlight the benefits of hormone replacement therapy.